Amphastar Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $39.2M | $4.1M | $35.1M | $17.1M |
| FY2018 | $38.2M | $-8.6M | $46.8M | $16.7M |
| FY2019 | $41.8M | $207.0K | $41.6M | $17.3M |
| FY2020 | $57.3M | $23.4M | $33.9M | $20.5M |
| FY2021 | $98.0M | $70.5M | $27.5M | $18.7M |